Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Sanofi-Aventis
Relationship:   10% Owner
City:   Paris
State:   I0
   
Insider Summary:
  
   
Companies Owned :   11    
Direct Shares   75,668,031    

Indirect Shares

   26,048,661      
Direct Value   $2,826,957,638    

Indirect Value

   $1,877,527,091      
Total Shares   101,716,692      
Total Value   $4,704,484,729      


Translate Bio, Inc. $2,826,957,638 Translate Bio, Inc. $2,826,957,638
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    1   
    5    

     Stock price went up :
    0   
    2    
     Stock price went down :
    1   
    3    
   
     Gain/Loss Ratio :
   -1.0   
   -1.0   
     Percentage Gain/Loss :
   -17.8%
 -3.6%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Regulus Therapeutics Inc. RGLS 10% Owner 0 2014-02-04 5,053,779    Premium*  
            Humanigen Inc HGEN Former 10% owner 2013-01-31 0 2013-01-31 579,030    Premium*  
            Glycomimetics Inc GLYC 10% Owner 0 2013-11-06 1,193,625    Premium*  
            Regeneron Pharmaceuticals Inc REGN 2020-05-29 0 2020-06-09 279,766    Premium*  
            Alnylam Pharmaceuticals Inc ALNY 10% Owner 0 2017-05-31 10,554,134    Premium*  
            Scynexis Inc SCYX 10% Owner 0 2014-05-07 1,677,057    Premium*  
            Voyager Therapeutics, Inc. VYGR Former 10% owner 2015-11-10 0 2015-11-16 2,477,941    Premium*  
            Fulcrum Therapeutics, Inc. FULC 10% Owner 2019-07-22 0 2019-07-22 558,035    Premium*  
            Inozyme Pharma, Inc. INZY 10% Owner 2020-07-28 0 2020-07-28 520,125    Premium*  
            Icosavax, Inc. ICVX 10% Owner 2021-08-02 0 2021-08-02 3,155,169    Premium*  
            Translate Bio, Inc. TBIO 10% Owner 2021-09-14 75,668,031 2021-09-14 0    Premium*  
* Premium Members only  

Records found :    85         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 4
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
REGN Regeneron Pharmaceuticals... 10% Owner   –       –       •   2014-03-20 4 B $325.94 $19,033,511 I/I 57,957 18,178,250 1.5 -
REGN Regeneron Pharmaceuticals... 10% Owner   –       –       •   2014-03-17 4 B $328.32 $19,755,234 I/I 60,128 18,110,547 1.5 -
REGN Regeneron Pharmaceuticals... 10% Owner   –       –       •   2014-01-27 4 B $269.77 $20,386,044 I/I 74,685 15,891,638 1.5 -
REGN Regeneron Pharmaceuticals... 10% Owner   –       –       •   2014-09-12 4 B $345.07 $20,737,541 I/I 59,808 22,264,649 1.5 -
ALNY Alnylam Pharmaceuticals I... 10% Owner   –       –       •   2017-05-31 4 B $71.87 $21,381,397 I/I 297,501 10,554,134 1.5 -
REGN Regeneron Pharmaceuticals... 10% Owner   –       –       •   2014-03-07 4 B $304.21 $22,093,655 I/I 69,873 17,151,491 1.5 -
ALNY Alnylam Pharmaceuticals I... 10% Owner   –       –       •   2014-03-25 4 B $66.88 $23,036,682 I/I 344,448 9,110,786 1.5 -
REGN Regeneron Pharmaceuticals... 10% Owner   –       –       •   2014-01-28 4 B $273.44 $23,184,321 I/I 83,235 15,974,873 1.5 -
REGN Regeneron Pharmaceuticals... 10% Owner   –       –       •   2016-06-14 4 B $361.44 $23,552,859 I/I 64,731 23,418,396 1.5 -
REGN Regeneron Pharmaceuticals... 10% Owner   –       –       •   2014-03-06 4 B $338.64 $27,305,546 I/I 80,404 17,081,618 1.5 -
REGN Regeneron Pharmaceuticals... 10% Owner   –       –       •   2014-09-15 4 B $340.88 $27,802,187 I/I 80,824 22,345,473 1.5 -
REGN Regeneron Pharmaceuticals...   •       •       •   2017-08-23 4 B $475.97 $29,024,050 I/I 60,595 23,702,339 2.64 -
REGN Regeneron Pharmaceuticals... 10% Owner   –       –       •   2014-07-03 4 AB $309.46 $31,101,946 I/I 100,000 20,996,041 0 -
REGN Regeneron Pharmaceuticals...   •       •       •   2016-02-17 4 B $390.14 $31,496,728 I/I 80,000 23,353,665 0.01 -
REGN Regeneron Pharmaceuticals...   •       •       •   2016-02-16 4 B $387.43 $31,751,182 I/I 81,157 23,273,665 0.01 -
REGN Regeneron Pharmaceuticals...   •       •       •   2017-01-11 4 B $362.47 $32,274,872 I/I 87,298 23,505,694 2.64 -
REGN Regeneron Pharmaceuticals...   •       •       •   2017-08-25 4 B $479.19 $34,840,133 I/I 72,378 23,880,537 2.64 -
REGN Regeneron Pharmaceuticals... 10% Owner   –       –       •   2015-10-06 4 B $449.14 $37,024,197 I/I 80,538 23,097,530 1.5 -
REGN Regeneron Pharmaceuticals...   •       •       •   2018-06-08 4 S $309.31 $37,611,882 I/I (121,601) 23,758,936 0 -
REGN Regeneron Pharmaceuticals... 10% Owner   –       –       •   2016-01-12 4 B $453.89 $39,034,660 I/I 83,938 23,192,508 1.5 -
REGN Regeneron Pharmaceuticals... 10% Owner   –       –       •   2014-07-15 4 AB $310.18 $40,656,176 I/I 129,100 22,204,841 0 -
REGN Regeneron Pharmaceuticals... 10% Owner   –       –       •   2014-10-16 4 AB $328.47 $40,955,057 I/I 122,127 22,657,685 0 -
REGN Regeneron Pharmaceuticals... 10% Owner   –       –       •   2014-02-06 4 B $282.84 $42,008,390 I/I 146,525 16,727,634 1.5 -
REGN Regeneron Pharmaceuticals...   •       •       •   2018-09-06 4 S $406.68 $42,519,249 I/I (104,552) 23,654,384 0 -
REGN Regeneron Pharmaceuticals... 10% Owner   –       –       •   2014-07-11 4 AB $311.39 $47,311,836 I/I 150,000 21,925,741 0 -
  85  Records found
  1   2  3   4      
  Page 2 of 4  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us